Business
Result of open offer
Result of open offer.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n\n\n\n\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.\nFURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.\n\n\n\n\n \n\n\n21 June 2024\n\n\n\n\n \nANGLE plc (the \"Company\")\n \nResults of Open Offer\n \nANGLE plc (AIM:AGL), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce that, pursuant to the Open Offer announced on 5 June 2024, it has received valid applications for a total of 3,561,121 Open Offer Shares from Qualifying Shareholders.\n \nThe Open Offer raised gross proceeds of £0.5m at the Issue Price, which will be used to strengthen the Company's balance sheet. In aggregate, £9.3m of gross proceeds have been raised pursuant to the Placing, Subscription and Open Offer.\n \nThe Open Offer Shares, when issued, will be fully paid and rank pari passu in all respects with the existing ordinary shares of the Company. Application has been made for the Open Offer Shares to be admitted to trading on AIM. Admission and settlement of the Open Offer Shares is expected to take place at 8.00 a.m. on 24 June 2024.\n \nTotal voting rights\n \nFollowing Second Admission, the Company will have a total of 322,641,668 ordinary shares in issue. With effect from Second Admission, this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.\n \nUnless otherwise stated, capitalised terms not otherwise defined in the text of this announcement have the same meanings ascribed to them as in the Launch Announcement published by the Company on 5 June 2024.\n \n \nFor further information:\n \n\n\n\n\nANGLE plc\n\n\n+44 (0) 1483 343434\n\n\n\n\nAndrew Newland, Chief Executive\nIan ...